loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 208685 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    PTC Therapeutics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DEFLAZACORT (1)

    filter

    01 PTC THERAP (1)

    filter

    01 SUSPENSION;ORAL (1)

    filter

    01 22.75MG/ML (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Deflazacort

      PDF Supplier PDF
      URL Supplier Web Content
      SUSPENSION;ORAL
      22.75MG/ML
      EMFLAZA
      USA
      208685
      2017-02-09
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 208685

      Looking for CTD TGA MCC DOSSIER APPLICATION 208685 1

      19

      PTC Therapeutics, based in U.S.A, is a pharmaceutical company.

      One of their notable products is DEFLAZACORT, with a corresponding application number 208685 and regulatory information .

      proudly manufactured in the

      approval since 2017-02-09

      PTC Therapeutics's EMFLAZA SUSPENSION;ORAL, medication with 22.75MG/ML of DEFLAZACORT.

      Post Enquiry
      POST ENQUIRY